Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 2,000 shares at $220.00 ($440K) on 2022-08-01, disclosed to the SEC on 2022-08-02.
Open-market sale of $440k RGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |
| RGEN | SELL | 2021-01-06 | $1.4M | — | Filing → |